Product Images Sumatriptan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Sumatriptan NDC 70069-804 by Somerset Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton1 - carton1 label

carton1 - carton1 label

This is a prescription drug with the name Sumatriptan. It is available in the form of a single-dose vial containing 6mg of sumatriptan succinate in 0.5mL solution. The drug is meant for subcutaneous injection only and contains 3.5mg of sodium chioride. It is manufactured in India and distributed by Somerset Therapeutics LLC located in Hollywood, Florida, USA. The drug product should be stored at a temperature between 2°C to 30°C and light should be avoided. Please refer to the prescribing information for dosage information. The patient information leaflet should also be dispensed by the pharmacist.*

carton5 - carton5 label

carton5 - carton5 label

This appears to be a label containing information about a medication called Sumatriptan Injection USP. It includes details such as the dosage (6mg/0.5mL), administration method (subcutaneous injection), and where it was manufactured (Somerset). It also mentions that certain details, such as lot number and expiration date, will be printed during the online packing process.*

vial-label - label vial

vial-label - label vial

This is a medication packaging for Sumatriptan Injection used for subcutaneous injection with a dosage of 6mg/0.5mL manufactured by Somsract Thrapentice/LIS & USP in Hollywood, FL. The package contains a single-dose vial with a discard instruction for unused portions and a code "TN/Drugs/TN00003457". It is recommended to protect the medication from light, and the vial has an expiry date of "18x7mm".*

Sumatriptan-Image01 - sumatriptan image01

Sumatriptan-Image01 - sumatriptan image01

image2 - sumatriptan image02

image2 - sumatriptan image02

This appears to be a chart showing the estimated percentage of patients experiencing relief, possibly from a medication or treatment. It includes information on a placebo group (N = 127) and a group taking Sumatriptan (N = 131) over a period of 25 minutes. However, without additional context or information, it is difficult to determine the specific context or implications of this data.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.